Global Pharmaceutical Pellets Market Strategies 2024, Forecast To 2033
8 Mar, 2024
The pharmaceutical pellets market has experienced rapid growth, rising from $1.66 billion in 2023 to $1.86 billion in 2024, with a CAGR of 12.1%. This growth is driven by demand for oral dosage forms. The market is forecasted to reach $2.82 billion in 2028, with a CAGR of 10.9%, fueled by pediatric dosage forms and continuous manufacturing. Major trends include 3D printing and smart coatings.
Global Pharmaceutical Pellets Market Key Driver
The pharmaceutical pellets market is poised for growth driven by the increasing prevalence of chronic diseases worldwide. Chronic diseases, lasting for a year or longer, require continuous medical care and significantly impact daily life. Pharmaceutical pellets offer advantages in treating chronic conditions by reducing digestive issues and improving drug absorption. With projections indicating a 99.5% surge in individuals aged 50 years and older with at least one chronic illness by 2050, as reported by the National Center for Biotechnology Information, the demand for pharmaceutical pellets is expected to rise, propelled by the imperative to address the growing burden of chronic diseases.
Get A Free Sample Of The Global Pharmaceutical Pellets Market ReportGlobal Pharmaceutical Pellets Market Segments
The pharmaceutical pellets market covered in this report is segmented –
1) Technology:Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution And Suspension Layering, Spray Congealing, Spray Drying
2) Mechanism Of Action:Diffusion, Erosion, Osmosis
3) Technique:Direct, Melt, Wet, Dry
4) End-User:Pharmaceutical, Nutraceutical
By Geography: The countries covered in the pharmaceutical pellets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the pharmaceutical pellets market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical pellets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Pharmaceutical Pellets Industry Players
Abbott Laboratories; Takeda; Boehringer Ingelheim; Teva Pharmaceutical Industries Ltd.; Eisai Co. Ltd.; Colorcon Inc.; Nordic Sugar AB; Pfizer; Merck & Co.; Manus Aktteva Biopharma LLP; Thexa Pharma (P) Limited; Avanscure Lifesciences Private Limited; U.K. Vet Chem; MB Sugars & Pharmaceuticals Limited; CIL Laboratories Pvt Ltd; Sainor Pharma Pvt Ltd; Umang Pharmatech Pvt Ltd; Nami Lifesciences Pvt Ltd; Lograns Pharma Private Limited; Rainbow Health Care Products; Chemit Laboratories; Concord Drugs Limited; Pharmaceuticals Private Limited; Nanjing Joyfulchem ??Co. Ltd.; Praful International Corporation; Pellets Pharma Limited; A B Enterprises; Vision Pharmacoat Pvt Ltd; Chemit Laboratories; Spansules Pharma; Ravoos Laboratories Ltd
Get The Full Global Pharmaceutical Pellets Market Report
Pharmaceutical Pellets Market Overview
Pharmaceutical pellets refer to a type of multi-particulate dosage form created by combining medications with finely ground excipients to create small, free-flowing, spherical, or semi-spherical particles. It is used to produce medication dose forms with prolonged release.